Salud Pública y Materno-Infantil
Departamento
![Foto de Salud Pública y Materno-Infantil](/img/noimage.png)
![Foto de Hospital Universitario Virgen del Rocío](/img/noimage_org.png)
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (222)
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment
Biomedicine and Pharmacotherapy, Vol. 173
-
Correction to: Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia (Annals of Hematology, (2024), 103, 5, (1525-1539), 10.1007/s00277-024-05694-z)
Annals of Hematology
-
Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR)
Annals of Hematology, Vol. 103, Núm. 8, pp. 2743-2755
-
Human gut microbiota analysis of cystic fibrosis infants using metaproteomics
Microbiology Resource Announcements, Vol. 13, Núm. 6
-
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study
Journal of Allergy and Clinical Immunology, Vol. 153, Núm. 1, pp. 275-286.e18
-
Palliative care for children with central nervous system tumors: results of a Spanish multicenter study
Clinical and Translational Oncology, Vol. 26, Núm. 3, pp. 786-795
-
Re-irradiation for progressive Diffuse Intrinsic Pontine Glioma (DIPG): The Spanish experience
EJC Paediatric Oncology, Vol. 4
-
Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia
Annals of Hematology, Vol. 103, Núm. 5, pp. 1525-1539
-
Tuberculosis Disease in Immunocompromised Children and Adolescents: A Pediatric Tuberculosis Network European Trials Group Multicenter Case-control Study
Clinical Infectious Diseases, Vol. 79, Núm. 1, pp. 215-222
2023
-
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity
Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 4, pp. 984-996.e10
-
Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age
Antibiotics, Vol. 12, Núm. 2
-
Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice
Antibiotics, Vol. 12, Núm. 3
-
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research
-
Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease
Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565
-
Failure of early non-invasive ventilation in preterm infants with respiratory distress syndrome in current care practice in Spanish level-III neonatal intensive care units – a prospective observational study
Frontiers in Pediatrics, Vol. 11
-
Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy
Biomedicine and Pharmacotherapy, Vol. 162
-
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome
Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 4, pp. 1081-1095
-
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research, Vol. 194